Role of the IL-33-ST2 axis in sepsis
Open Access
- 2 February 2017
- journal article
- review article
- Published by Elsevier in Military Medical Research
- Vol. 4 (1) , 1-9
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (RO1GM044100)
- National Institutes of Health (RO1GM050441)
This publication has 128 references indexed in Scilit:
- Rapid induction of inflammatory lipid mediators by the inflammasome in vivoNature, 2012
- IL‐33 synergizes with TCR and IL‐12 signaling to promote the effector function of CD8+ T cellsEuropean Journal of Immunology, 2011
- Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunityNature Immunology, 2011
- Amplification of cytokine production through synergistic activation of NFAT and AP‐1 following stimulation of mast cells with antigen and IL‐33European Journal of Immunology, 2011
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature, 2010
- Soluble ST2 plasma concentrations predict mortality in severe sepsisIntensive Care Medicine, 2010
- IL-33–activated dendritic cells induce an atypical TH2-type responseJournal of Allergy and Clinical Immunology, 2009
- Molecular mimicry between IL‐33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocketEMBO Reports, 2008
- A novel IL-1 family cytokine, IL-33, potently activates human eosinophilsJournal of Allergy and Clinical Immunology, 2008